Review



rabbit anti human type xii collagen primary antibodies  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Novus Biologicals rabbit anti human type xii collagen primary antibodies
    A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies <t>against</t> <t>collagen</t> VI (D, E) and <t>XII</t> (F, G).
    Rabbit Anti Human Type Xii Collagen Primary Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human type xii collagen primary antibodies/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit anti human type xii collagen primary antibodies - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "Accelerated Bone Healing in Calvarial and Femoral Defects with Injectable Microcarriers that Mimic the Osteogenic Niche"

    Article Title: Accelerated Bone Healing in Calvarial and Femoral Defects with Injectable Microcarriers that Mimic the Osteogenic Niche

    Journal: bioRxiv

    doi: 10.1101/2021.11.05.467478

    A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies against collagen VI (D, E) and XII (F, G).
    Figure Legend Snippet: A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies against collagen VI (D, E) and XII (F, G).

    Techniques Used: Immunofluorescence

    Effects of OCM and GW9662 on collagen and BMP-2 gene expression. Quantitative PCR was used to quantify the effects 10uM GW9662 and OCM on transcription of collagen VI (A) and collagen XII (B) on Day 8. (C) GW9662 and OCM-GelMA synergistically upregulated BMP-2 expression on Day 8. Data is presented as fold-change in gene expression relative to hMSC monolayers in Complete Culture Media. Statistics are (n=3) one sided ANOVA and Tukey post test ** represents p<0.005. All data presented as average ± s.d. All experiments performed in triplicate.
    Figure Legend Snippet: Effects of OCM and GW9662 on collagen and BMP-2 gene expression. Quantitative PCR was used to quantify the effects 10uM GW9662 and OCM on transcription of collagen VI (A) and collagen XII (B) on Day 8. (C) GW9662 and OCM-GelMA synergistically upregulated BMP-2 expression on Day 8. Data is presented as fold-change in gene expression relative to hMSC monolayers in Complete Culture Media. Statistics are (n=3) one sided ANOVA and Tukey post test ** represents p<0.005. All data presented as average ± s.d. All experiments performed in triplicate.

    Techniques Used: Gene Expression, Real-time Polymerase Chain Reaction, Expressing



    Similar Products

    90
    Novus Biologicals rabbit anti human type xii collagen primary antibodies
    A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies <t>against</t> <t>collagen</t> VI (D, E) and <t>XII</t> (F, G).
    Rabbit Anti Human Type Xii Collagen Primary Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human type xii collagen primary antibodies/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit anti human type xii collagen primary antibodies - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    91
    Novus Biologicals human type xii collagen
    A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies <t>against</t> <t>collagen</t> VI (D, E) and <t>XII</t> (F, G).
    Human Type Xii Collagen, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human type xii collagen/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    human type xii collagen - by Bioz Stars, 2026-05
    91/100 stars
      Buy from Supplier

    Image Search Results


    A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies against collagen VI (D, E) and XII (F, G).

    Journal: bioRxiv

    Article Title: Accelerated Bone Healing in Calvarial and Femoral Defects with Injectable Microcarriers that Mimic the Osteogenic Niche

    doi: 10.1101/2021.11.05.467478

    Figure Lengend Snippet: A) Schematic diagram of the steps to obtaining OCM-coated microcarriers. B-C: Representative low- and high-resolution SEM micrographs of GelMA (B, B’) and OCM-GelMA (C, C’) microcarriers. D-G) Representative immunofluorescence images of GelMA (D,F) and OCM-GelMA (E,G) microcarriers with antibodies against collagen VI (D, E) and XII (F, G).

    Article Snippet: Microcarriers were incubated overnight at 4°C in blocking buffer with rabbit anti-human type VI collagen and rabbit anti-human type XII collagen primary antibodies (each 1:200, Novus Biologicals, Littleton, CO).

    Techniques: Immunofluorescence

    Effects of OCM and GW9662 on collagen and BMP-2 gene expression. Quantitative PCR was used to quantify the effects 10uM GW9662 and OCM on transcription of collagen VI (A) and collagen XII (B) on Day 8. (C) GW9662 and OCM-GelMA synergistically upregulated BMP-2 expression on Day 8. Data is presented as fold-change in gene expression relative to hMSC monolayers in Complete Culture Media. Statistics are (n=3) one sided ANOVA and Tukey post test ** represents p<0.005. All data presented as average ± s.d. All experiments performed in triplicate.

    Journal: bioRxiv

    Article Title: Accelerated Bone Healing in Calvarial and Femoral Defects with Injectable Microcarriers that Mimic the Osteogenic Niche

    doi: 10.1101/2021.11.05.467478

    Figure Lengend Snippet: Effects of OCM and GW9662 on collagen and BMP-2 gene expression. Quantitative PCR was used to quantify the effects 10uM GW9662 and OCM on transcription of collagen VI (A) and collagen XII (B) on Day 8. (C) GW9662 and OCM-GelMA synergistically upregulated BMP-2 expression on Day 8. Data is presented as fold-change in gene expression relative to hMSC monolayers in Complete Culture Media. Statistics are (n=3) one sided ANOVA and Tukey post test ** represents p<0.005. All data presented as average ± s.d. All experiments performed in triplicate.

    Article Snippet: Microcarriers were incubated overnight at 4°C in blocking buffer with rabbit anti-human type VI collagen and rabbit anti-human type XII collagen primary antibodies (each 1:200, Novus Biologicals, Littleton, CO).

    Techniques: Gene Expression, Real-time Polymerase Chain Reaction, Expressing